Literature DB >> 21358944

Multidisciplinary reference centers: the care of neuroendocrine tumors.

Simron Singh1, Calvin Law.   

Abstract

The purpose of this study was to review the need for and benefits of multidisciplinary care in patients with cancer, to describe our experience setting up a multidisciplinary reference center (MRC) dedicated to the treatment of the uncommon cancer neuroendocrine tumors (NETs), and to present the perspective of a patient seeking treatment at our center.The literature was searched to review the outcomes of patients with cancer treated by a multidisciplinary team.Multidisciplinary care for patients with more common cancers has been associated with improvements in diagnosis, treatment planning, survival, patient satisfaction, and clinician satisfaction. Similar benefits have been seen in patients with NETs receiving treatment at a specialty center. The establishment of our NETs MRC allows us to offer integrated care, providing surgical oncology and medical oncology disciplines; nurses well experienced in the treatment of NETs; and the expertise of endocrinology, diagnostic radiology, and interventional radiology specialists. Since our clinic was established, we have increased our availability to see patients and have received positive feedback from those attending.MRCs have been associated with improved patient outcomes. As providers at a dedicated NETs MRC, we feel that these centers have a positive effect on both patient and provider experience. The creation of specialty centers with a focus on improving outcomes and quality of care should be a goal of health care systems and are especially important for patients with NETs and other rare cancers.

Entities:  

Year:  2010        PMID: 21358944      PMCID: PMC2988672          DOI: 10.1200/JOP.2010.000098

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  20 in total

1.  Clinical trials in lung cancer: evidence that a programmed investigation unit and a multidisciplinary clinic may improve recruitment.

Authors:  L R Magee; C M Laroche; D Gilligan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

2.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Multidisciplinary breast cancer clinics. Do they work?

Authors:  M Gabel; N E Hilton; S D Nathanson
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

Review 4.  Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment.

Authors:  Kjell Oberg
Journal:  Curr Opin Oncol       Date:  2005-07       Impact factor: 3.645

Review 5.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

6.  Metastatic carcinoid tumor: changing patterns of care over two decades.

Authors:  Amanda Townsend; Tim Price; Sue Yeend; Ken Pittman; Kevin Patterson; Colin Luke
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

7.  Multidisciplinary care for women with early breast cancer in the Australian context: what does it mean?

Authors:  Helen Zorbas; Bruce Barraclough; Kathy Rainbird; Karen Luxford; Sally Redman
Journal:  Med J Aust       Date:  2003-11-17       Impact factor: 7.738

8.  Management of ovarian cancer: referral to a multidisciplinary team matters.

Authors:  E J Junor; D J Hole; C R Gillis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

9.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; D J Dunlop
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

10.  Effect of process standards on survival of patients with head and neck cancer in the south and west of England.

Authors:  M Birchall; D Bailey; P King
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more
  13 in total

Review 1.  Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

Authors:  Zu-Yi Ma; Yuan-Feng Gong; Hong-Kai Zhuang; Zi-Xuan Zhou; Shan-Zhou Huang; Yi-Ping Zou; Bo-Wen Huang; Zhong-Hai Sun; Chuan-Zhao Zhang; Yun-Qiang Tang; Bao-Hua Hou
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

2.  Access to care and outcomes for neuroendocrine tumours: does socioeconomic status matter?

Authors:  J Hallet; N G Coburn; S Singh; K Beyfuss; S Koujanian; N Liu; C H L Law
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

3.  Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise.

Authors:  Mirco Bartolomei; Alfredo Berruti; Massimo Falconi; Nicola Fazio; Diego Ferone; Secondo Lastoria; Giovanni Pappagallo; Ettore Seregni; Annibale Versari
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

4.  Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor.

Authors:  Gianluca Tamagno; Kieran Sheahan; Stephen J Skehan; Justin G Geoghegan; David Fennelly; Conor D Collins; Donal Maguire; Oscar Traynor; David P Brophy; Colin Cantwell; Niall Swan; Lisa McGowan; Dermot O'Toole; Donal O'Shea
Journal:  Endocrine       Date:  2013-03-08       Impact factor: 3.633

Review 5.  Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations.

Authors:  Edward M Wolin
Journal:  Oncologist       Date:  2015-08-25

6.  Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.

Authors:  M M Vickers; J Pasieka; E Dixon; S McEwan; A McKay; D Renouf; D Schellenberg; D Ruether
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

Review 7.  The Landmark Series: Management of Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

8.  Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.

Authors:  Simron Singh; Dan Granberg; Edward Wolin; Richard Warner; Maia Sissons; Teodora Kolarova; Grace Goldstein; Marianne Pavel; Kjell Öberg; John Leyden
Journal:  J Glob Oncol       Date:  2016-06-08

9.  Late anastomotic perforation following surgery for gastric neuroendocrine tumor complicated by perforated duodenal ulcer: a case report.

Authors:  Jun Han; Zhenyu He
Journal:  J Biomed Res       Date:  2012-03-29

10.  Diagnostic and Management Pathways for Pulmonary Carcinoid Tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project.

Authors:  Wasat Mansoor; Stuart Ferguson; Victoria Ross; Denis Talbot
Journal:  Int J Endocrinol       Date:  2020-02-28       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.